210 related articles for article (PubMed ID: 16879968)
1. Novel A-ring homodimeric C-3-carbamate analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
Oves D; Fernández S; Verlinden L; Bouillon R; Verstuyf A; Ferrero M; Gotor V
Bioorg Med Chem; 2006 Nov; 14(22):7512-9. PubMed ID: 16879968
[TBL] [Abstract][Full Text] [Related]
2. Novel A-ring analogs of the hormone 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation.
Posner GH; Lee SH; Kim HJ; Peleg S; Dolan P; Kensler TW
Bioorg Med Chem; 2005 Apr; 13(8):2959-66. PubMed ID: 15781405
[TBL] [Abstract][Full Text] [Related]
3. Chemoenzymatic synthesis and biological evaluation of C-3 carbamate analogues of 1alpha,25-dihydroxyvitamin D3.
Gotor-Fernández V; Fernández S; Ferrero M; Gotor V; Bouillon R; Verstuyf A
Bioorg Med Chem; 2004 Oct; 12(20):5443-51. PubMed ID: 15388171
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of previtamin D(3) analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
Bioorg Med Chem; 2008 Dec; 16(24):10244-50. PubMed ID: 19006670
[TBL] [Abstract][Full Text] [Related]
5. Analogs of 1alpha,25-dihydroxyvitamin D3 with high potency in induction of osteoclastogenesis and prevention of dendritic cell differentiation: synthesis and biological evaluation of 2-substituted 19-norvitamin D analogs.
Shimazaki M; Miyamoto Y; Yamamoto K; Yamada S; Takami M; Shinki T; Udagawa N; Shimizu M
Bioorg Med Chem; 2006 Jul; 14(13):4645-56. PubMed ID: 16513359
[TBL] [Abstract][Full Text] [Related]
6. Versatile synthesis and biological evaluation of 1,3-diamino-substituted 1alpha,25-dihydroxyvitamin D3 analogues.
Oves D; Fernández S; Ferrero M; Bouillon R; Verstuyf A; Gotor V
Bioorg Med Chem; 2006 Feb; 14(4):928-37. PubMed ID: 16213141
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary biological evaluation of new antiproliferative aromatic analogues of 1α,25-dihydroxyvitamin D3.
Thomas E; Brion JD; Peyrat JF
Eur J Med Chem; 2014 Oct; 86():381-93. PubMed ID: 25180926
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20.
Zhou X; Zhu GD; Van Haver D; Vandewalle M; De Clercq PJ; Verstuyf A; Bouillon R
J Med Chem; 1999 Sep; 42(18):3539-56. PubMed ID: 10479287
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.
Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M
J Med Chem; 2009 Oct; 52(19):6158-62. PubMed ID: 19739672
[TBL] [Abstract][Full Text] [Related]
10. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 1,25-dihydroxyvitamin D3 analogues having a spiro-oxetane fused at the C2 position in the A-ring.
Fujishima T; Nozaki T; Suenaga T
Bioorg Med Chem; 2013 Sep; 21(17):5209-17. PubMed ID: 23845283
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues.
Demin S; Van Haver D; Vandewalle M; De Clercq PJ; Bouillon R; Verstuyf A
Bioorg Med Chem Lett; 2004 Aug; 14(15):3885-8. PubMed ID: 15225690
[TBL] [Abstract][Full Text] [Related]
13. Methyl-introduced A-ring analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and biological evaluation.
Fujishima T; Tsutsumi R; Negishi Y; Fujii S; Takayama H; Kittaka A; Kurihara M
Anticancer Res; 2006; 26(4A):2633-6. PubMed ID: 16886673
[TBL] [Abstract][Full Text] [Related]
14. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K
J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D3 analogues with aromatic side chains attached at C-17.
Liu C; Zhao GD; Mao X; Suenaga T; Fujishima T; Zhang CM; Liu ZP
Eur J Med Chem; 2014 Oct; 85():569-75. PubMed ID: 25127149
[TBL] [Abstract][Full Text] [Related]
16. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH
J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
Kato Y; Nakano Y; Sano H; Tanatani A; Kobayashi H; Shimazawa R; Koshino H; Hashimoto Y; Nagasawa K
Bioorg Med Chem Lett; 2004 May; 14(10):2579-83. PubMed ID: 15109656
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a 3-position diastereomer of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D3 (ED-71).
Hatakeyama S; Nagashima S; Imai N; Takahashi K; Ishihara J; Sugita A; Nihei T; Saito H; Takahashi F; Kubodera N
Bioorg Med Chem; 2006 Dec; 14(23):8050-6. PubMed ID: 16908172
[TBL] [Abstract][Full Text] [Related]
19. Pd-catalyzed carbocyclization-Negishi cross-coupling cascade: a novel approach to 1alpha,25-dihydroxyvitamin D3 and analogues.
Gómez-Reino C; Vitale C; Maestro M; Mouriño A
Org Lett; 2005 Dec; 7(26):5885-7. PubMed ID: 16354091
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of C-2 substituted vitamin D derivatives having ringed side chains and their biological evaluation, especially biological effect on bone by modification at the C-2 position.
Saitoh H; Chida T; Takagi K; Horie K; Sawai Y; Nakamura Y; Harada Y; Takenouchi K; Kittaka A
Org Biomol Chem; 2011 May; 9(10):3954-64. PubMed ID: 21472188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
